HIK.L
Price:
$1830
Market Cap:
$5.28B
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovasc...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2005-11-01
Stock Exchange
LSE
Ticker
HIK.L
According to Hikma Pharmaceuticals PLC’s latest financial reports and current stock price. The company's current Enterprise Value is 6.27B. This represents a change of 4.77% compared to the average of 5.98B of the last 4 quarters.
The mean historical Enterprise Value of Hikma Pharmaceuticals PLC over the last ten years is 6.32B. The current 6.27B Enterprise Value has changed 9.83% with respect to the historical average. Over the past ten years (40 quarters), HIK.L's Enterprise Value was at its highest in in the December 2020 quarter at 8.62B. The Enterprise Value was at its lowest in in the December 2010 quarter at 101.13M.
Average
6.32B
Median
6.26B
Minimum
4.14B
Maximum
8.72B
Discovering the peaks and valleys of Hikma Pharmaceuticals PLC Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 52.21%
Maximum Annual Enterprise Value = 8.72B
Minimum Annual Increase = -32.58%
Minimum Annual Enterprise Value = 4.14B
Year | Enterprise Value | Change |
---|---|---|
2023 | 6.02B | 15.48% |
2022 | 5.21B | -29.19% |
2021 | 7.36B | -15.68% |
2020 | 8.72B | 31.64% |
2019 | 6.63B | 17.73% |
2018 | 5.63B | 35.91% |
2017 | 4.14B | -32.58% |
2016 | 6.14B | -11.24% |
2015 | 6.92B | 8.40% |
2014 | 6.38B | 52.21% |
The current Enterprise Value of Hikma Pharmaceuticals PLC (HIK.L) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.19B
5-year avg
6.79B
10-year avg
6.32B
Hikma Pharmaceuticals PLC’s Enterprise Value is less than Intertek Group plc (8.65B), less than Mondi plc (8.07B), less than Halma plc (10.15B), less than Bunzl plc (12.83B), less than Smith & Nephew plc (14.13B),
Company | Enterprise Value | Market cap |
---|---|---|
8.65B | $7.64B | |
8.07B | $5.53B | |
10.15B | $9.49B | |
12.83B | $11.50B | |
14.13B | $8.49B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hikma Pharmaceuticals PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hikma Pharmaceuticals PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Hikma Pharmaceuticals PLC's Enterprise Value?
What is the highest Enterprise Value for Hikma Pharmaceuticals PLC (HIK.L)?
What is the 3-year average Enterprise Value for Hikma Pharmaceuticals PLC (HIK.L)?
What is the 5-year average Enterprise Value for Hikma Pharmaceuticals PLC (HIK.L)?
How does the current Enterprise Value for Hikma Pharmaceuticals PLC (HIK.L) compare to its historical average?